Substance Use

Updated mRNA COVID-19 vaccines, the first orally disintegrating tablet approved for pregnancy prevention, and 5 more.

Find key results from a new survey examining Americans' attitudes, beliefs, and knowledge about opioid use disorder treatment in primary care, here.

The FDA requested an additional human factors study and more technical data on the final commercial product.

ICYMI: A quick look at 7 key drugs FDA-approved in the second quarter for conditions commonly seen in primary care.

Your daily dose of the clinical news you may have missed.

Findings from a national survey also showed that Black respondents were most likely to believe they could not receive medications for OUD at a PCP.

Your daily dose of the clinical news you may have missed.

Findings from 2 early stage studies reported at a recent clinical meeting support the safety and tolerability of the GLP-1RA in persons with substance use disorders.

A concise update on legal status, FDA approvals, patient safety, and public perception.

Which state has the lowest percentage of teen drug users? Or the highest percentage of adults with unmet drug-treatment needs? Answers from a new report, here.

Your daily dose of the clinical news you may have missed.

AUA 2024. Neither use of alcohol nor vaping/cigarette smoking by either parent during preconception was "appreciably" linked to an incident event, new research found.

Your daily dose of the clinical news you may have missed.

ACC.24: Even modest alcohol intake increases risk for coronary heart disease in men and women but women are at much greater risk across levels of weekly consumption.

Your daily dose of the clinical news you may have missed.

The risk for cardiovascular outcomes increased with more frequent reported cannabis use per month, according to results from a large national study.

Your daily dose of the clinical news you may have missed.

Access to methadone and buprenorphine treatment may be easier and incentive to continue treatment could start at home, using telehealth, according to HHS.

Past month use of cannabis was associated with 43% greater odds of asthma than no use of the drug; odds were 2-fold greater with use of blunts.

Risk of mortality from ALD and MetALD was significantly higher among women even though both phenotypes were more prevalent among men, a new study reveals.

Reported adverse events of products with tianeptine include seizures, loss of consciousness, and death, according to the FDA.

The investigational combination opioid from Ensysce Biosciences is designed to deter abuse as well as prevent accidental or intentional overdose, the company said.

This second shelf-life extension for the OTC naloxone hydrochloride 4 mg spray continues the FDA's campaign to prevent drug overdose and related fatalities.

Investigators found that the gender life expectancy gap increased 0.23 years from 2010 to 2019 and 0.70 years from 2019 to 2021.

Your daily dose of the clinical news you may have missed.

Primary Care Alert: Risky alcohol use in the past year was found highest among persons taking benzodiazepines, followed by those taking opioids, and taking antiepileptics.

Your daily dose of clinical news you may have missed.

Atrial fibrillation prevalence is rising across socioeconomic strata globally, the new analysis finds, with effects of BMI, ETOH, and sedentary behavior shifting as key drivers.

A daily dose of clinical news on Patient Care you may have missed.

Despite a 20-pack year smoking history and frequent respiratory exacerbations, spirometry is preserved in this group of heavy smokers.